OMEICOS Therapeutics

0 followers

‌

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.

Industries

Headquarters

Stage

Employees

Links

Org chart

Co-Founder, CEO & CSO

Robert Fischer

Collapse

CBO, Consultancy

VP of Operations & IP, Co-Founder

Head of Finance & Controlling

Klinischer Projektmanager

Head in-vivo Pharmacology

NEW WORK SE

1 follower

Luminovo

3 followers

Volkswagen Group

93 followers

Bosch

60 followers

Celonis

92 followers

Discover companies